D Jefferson|C D Marsden - JoVE Visualize

Showing results (751-760 of 818) with videos related to

Pageof 82

Sort By:

Neuroscience Letters|October 23, 1989

Inclusion bodies in motor cortex and brainstem of patients with motor neurone disease are detected by immunocytochemical localisation of ubiquitinJ Lowe, F Aldridge, G Lennox, et al.

Journal of Education & Teaching in Emergency Medicine|July 19, 2023

Tracheoinnominate Artery FistulaEmily M Tarver, Anna A Lerant, Jeffrey D Orledge, et al.

Brain : a Journal of Neurology|June 1, 1996

Tremor associated with benign IgM paraproteinaemic neuropathyP G Bain, T C Britton, I H Jenkins, et al.

Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's diseaseP A Löschmann, K W Lange, M Kunow, et al.

Annals of Neurology|July 1, 1993

A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connectionsI H Jenkins, P G Bain, J G Colebatch, et al.

Journal of Neurochemistry|July 1, 1990

Decreased ferritin levels in brain in Parkinson's diseaseD T Dexter, A Carayon, M Vidailhet, et al.

Annals of Neurology|October 1, 1990

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyD J Brooks, V Ibanez, G V Sawle, et al.

Journal of Neurophysiology|May 1, 1997

Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputeesJ J Kew, P W Halligan, J C Marshall, et al.

Neurology|March 1, 1995

Acanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome)R W Orrell, P J Amrolia, A Heald, et al.

Neuropeptides|October 1, 1988

Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatmentH Taquet, M Nomoto, S Rose, et al.

Pageof 82

Showing results (751-760 of 818) with videos related to

Sort By:

Pageof 82

Neuroscience Letters|October 23, 1989

Inclusion bodies in motor cortex and brainstem of patients with motor neurone disease are detected by immunocytochemical localisation of ubiquitinJ Lowe, F Aldridge, G Lennox, et al.

Journal of Education & Teaching in Emergency Medicine|July 19, 2023

Tracheoinnominate Artery FistulaEmily M Tarver, Anna A Lerant, Jeffrey D Orledge, et al.

Brain : a Journal of Neurology|June 1, 1996

Tremor associated with benign IgM paraproteinaemic neuropathyP G Bain, T C Britton, I H Jenkins, et al.

Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's diseaseP A Löschmann, K W Lange, M Kunow, et al.

Annals of Neurology|July 1, 1993

A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connectionsI H Jenkins, P G Bain, J G Colebatch, et al.

Journal of Neurochemistry|July 1, 1990

Decreased ferritin levels in brain in Parkinson's diseaseD T Dexter, A Carayon, M Vidailhet, et al.

Annals of Neurology|October 1, 1990

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyD J Brooks, V Ibanez, G V Sawle, et al.

Journal of Neurophysiology|May 1, 1997

Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputeesJ J Kew, P W Halligan, J C Marshall, et al.

Neurology|March 1, 1995

Acanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three patients, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome)R W Orrell, P J Amrolia, A Heald, et al.

Neuropeptides|October 1, 1988

Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatmentH Taquet, M Nomoto, S Rose, et al.

Pageof 82